GENCO Supply Chain Solutions Changes the Name of Its Pharmaceutical Business Unit

Share Article

Capital Returns Inc. will now be GENCO Pharmaceutical Services Launches New Pharmaceutical Services Web Site

We are committed to delivering the highest level of expertise, innovation, customer service and excellence for our customers.

GENCO Supply Chain Solutions, North America’s second largest and a Global Top 50 third-party logistics provider, today announced that it has changed the name of its wholly owned pharmaceutical subsidiary, Capital Returns Inc., to GENCO Pharmaceutical Services. To coincide with the name change, the company has launched a new Web site, http://www.gencopharma.com, which has been redesigned and updated with information about the latest service offerings.

The name change better represents the breadth of services to pharmaceutical manufacturers and retailers and reinforces the GENCO brand as an integrated company, reflecting the company's strategy to more closely align and strengthen the identity of each of its business units.

Since its founding in 1991 as Capital Returns Inc. and acquisition by GENCO in 2005, the company has been a driving force of innovation, resulting in the development of many pharmaceutical industry firsts.

"Our goal is to build upon our leadership position, excelling in the delivery of pharmaceutical returns and recall solutions," said Larry Hruska, president of GENCO Pharmaceutical Services. "We are committed to delivering the highest level of expertise, innovation, customer service and excellence for our customers."

GENCO Supply Chain Solutions is North America's second largest and a Global Top 50 third-party logistics provider and the recognized leader in Reverse Logistics. The company manages over 130 operations and 37 million square feet of warehouse space throughout North America for a diverse range of retail, manufacturing and government customers. The company provides initial and ongoing value through a complete range of solutions, including contract logistics, transportation logistics, parcel negotiation and audits, reverse logistics, damage research, product liquidation, pharmaceutical services, government solutions and technology solutions. For more information, visit http://www.genco.com.

Don Rendulic
Director, Marketing and Corporate Communications
412-820-3922

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Don Rendulic
GENCO
412-820-3922
Email >
Visit website